Trials / Completed
CompletedNCT02408055
ADME Study in Healthy Male Subjects With TA-8995
A Phase I Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolism and Excretion of 14C-TA-8995 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Xention Ltd · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TA-8995 |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-04-03
- Last updated
- 2016-10-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02408055. Inclusion in this directory is not an endorsement.